BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2050321)

  • 1. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.
    Woo Y; Ma M; Okawa M; Saito T
    Viruses; 2024 May; 16(5):. PubMed ID: 38793622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of seven interventions for chronic hepatitis D: a systematic review and network meta-analysis of randomized controlled trials.
    Rong Y; Ju X; Sun P; Wang Y
    BMC Infect Dis; 2023 Oct; 23(1):726. PubMed ID: 37880598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response.
    Chida T; Ishida Y; Morioka S; Sugahara G; Han C; Lam B; Yamasaki C; Sugahara R; Li M; Tanaka Y; Liang TJ; Tateno C; Saito T
    JCI Insight; 2023 May; 8(9):. PubMed ID: 37154158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent breakthroughs in the treatment of chronic hepatitis Delta.
    Brancaccio G; Gaeta L; Vitale A; Gaeta GB
    Infez Med; 2022; 30(2):204-210. PubMed ID: 35693059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis delta: A state-of-the-art review and new therapies.
    Gilman C; Heller T; Koh C
    World J Gastroenterol; 2019 Aug; 25(32):4580-4597. PubMed ID: 31528088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of Delta Hepatitis.
    Yurdaydin C; Idilman R
    Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26253093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha-2b therapy in chronic hepatitis delta.
    Keshvari M; Alavian SM; Sharafi H; Karimi G; Gholami Fesharaki M
    Hepat Mon; 2014 Mar; 14(3):e15729. PubMed ID: 24744790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical aspects of hepatitis D virus infections.
    Dastgerdi ES; Herbers U; Tacke F
    World J Virol; 2012 Jun; 1(3):71-8. PubMed ID: 24175212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.
    Alavian SM; Tabatabaei SV; Behnava B; Rizzetto M
    J Res Med Sci; 2012 Oct; 17(10):967-74. PubMed ID: 23825999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alpha for chronic hepatitis D.
    Abbas Z; Khan MA; Salih M; Jafri W
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD006002. PubMed ID: 22161394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.
    Andersen ES; Gerstoft J; Weis N
    Int J Hematol; 2010 Sep; 92(2):378-80. PubMed ID: 20686876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.
    Wedemeyer H; Manns MP
    Nat Rev Gastroenterol Hepatol; 2010 Jan; 7(1):31-40. PubMed ID: 20051970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.
    Chien RN
    Hepatol Int; 2008 Sep; 2(3):296-303. PubMed ID: 19669257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons and their use in persistent viral infections.
    Chevaliez S; Pawlotsky JM
    Handb Exp Pharmacol; 2009; 189(189):203-41. PubMed ID: 19048202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.
    Casey J; Cote PJ; Toshkov IA; Chu CK; Gerin JL; Hornbuckle WE; Tennant BC; Korba BE
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4396-9. PubMed ID: 16189132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
    Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
    J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha interferon and ribavirin combination therapy of chronic hepatitis D.
    Kaymakoglu S; Karaca C; Demir K; Poturoglu S; Danalioglu A; Badur S; Bozaci M; Besisik F; Cakaloglu Y; Okten A
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1135-8. PubMed ID: 15728914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B.
    Weakley T; Rajender Reddy K
    Curr Treat Options Gastroenterol; 1999 Dec; 2(6):463-472. PubMed ID: 11097730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide to the use of interferons in the management of hepatitis virus infections.
    Saracco G; Rizzetto M
    Drugs; 1997 Jan; 53(1):74-85. PubMed ID: 9010649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.